Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Wondering if a credit builder loan will improve loan approvals? We explain how these loans impact credit scores and lender perceptions.
14,314 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Long-term investors chase multibagger dreams. This article explores a high-potential biotech setup with 26 late-stage...
Eli Lilly is delivering big news for investors. The rallying force behind recent gains comes from GLP-1 drugs, manufa...
As the next market cycle approaches, traders are weighing XRP against Hyperliquid, weighing price action, liquidity, ...
Investors often chase compelling stories more than spreadsheets. This piece explores historical price dynamics and ho...
Regulators worldwide are accelerating a shift from perpetual swaps perpetual to regulated perpetual CFDs, reshaping a...
Coinbase faces a volatile crypto backdrop, but a broader push into institutional services and fintech partnerships co...
Tesla sits near the $400 mark as investors weigh future growth against current prices. This guide helps you decide wh...
Biotech investors watched Agios Pharmaceuticals spark a notable rally after key quarterly results and a strong Aqvesm...
Imagine AI agents that remember your preferences across wallets and apps. Walrus Memory makes that possible, letting ...
Sunrun jumped on news of a large-scale virtual power plant deal with Tesla and Renew Home, signaling a shift in distr...
After Johnson Johnson released its latest earnings, investors wonder: is this stock a buy? This guide breaks down the...